ZIEXTENZO sol inj 6 mg/0.6ml ser pré
7680675690015
CH-67569
L03AA13
06.07.3.
Reimbursement limitations:
NEULASTA
Administration au cours des chimiothérapies fortement myélotoxiques permettant d'espérer une évolution positive chez les patients …
1 / 3
google
Details
- Product number
- 6756901
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- pegfilgrastimum 6 mg, acidum aceticum, sorbitolum 30 mg, polysorbatum 20, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml corresp. natrium 0.007 mg.
Articles (1)
Ziextenzo 6 mg / 0.6 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
30.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.007 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1105.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2020
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67569
- Drug name
- Ziextenzo, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L03AA13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZIEXTENZO sol inj 6 mg/0.6ml ser pré
- Description (DE)
- ZIEXTENZO Inj Lös 6 mg/0.6ml Fertspr
- Market launch
- 20/01/2020
- Narcotic (BTM)
- No